Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00019097
Status:
COMPLETED
Last Update Posted:
2024-03-04
First Post:
2007-03-01
Brief Title:
Vaccine Therapy in Treating Patients With Multiple Myeloma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Plasma Cell Neoplasm |
| Stage II Multiple Myeloma |
| Stage III Multiple Myeloma |
Keywords:
| Name | View |
|---|---|
| stage plasma cell neoplasm | View |
| body systemsite cancer | View |
| cancer | View |
| genetic condition | View |
| hematopoieticlymphoid cancer | View |
| multiple myeloma | View |
| multiple myeloma and other plasma cell neoplasms | View |
| plasma cell neoplasm | View |
| refractory plasma cell neoplasm | View |
| stage II multiple myeloma | View |
| stage III multiple myeloma | View |